Concepedia
Statistics
Publications
13
Citations
793
H-Index
12
Active since
1959
Affiliations
Ashland (United States)(Current)
Harvard University
Kao Corporation (Japan)
University of California, San Francisco
John Knapp is an author at Ashland (United States) specializing in pharmacy, pharmacology, and toxicology.
Publications per year
1959–2009
Interpreting the toxicologic significance of alterations in anogenital distance: potential for confounding effects of progeny body weights
R. H. Gallavan, Joseph F. Holson, Donald G. Stump et al. · Reproductive Toxicology · 1999 · 275 citations
Pharmacy, Toxicology, Developmental Toxicology +8
Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studies
Norman Jaffe, John Knapp, Vincent P. Chuang et al. · Cancer · 1983 · 163 citations
Medicine, Oncology, Pharmacology +17
Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats
Joseph F. Holson, Donald G. Stump, Kerin J. Clevidence et al. · Food and Chemical Toxicology · 2000 · 75 citations
Pharmacy, Developmental Biology, Toxicology +14
Hypoglycemia Complicating Treatment of Phenylketonuria with a Phenylalanine-Deficient Diet
Philip R. Dodge, Elliott L. Mangall, John D. Crawford et al. · New England Journal of Medicine · 1959 · 48 citations
Life Sciences, Biochemistry, Pediatrics +12
Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.
N Jaffe, John F. Prudich, John Knapp et al. · Journal of Clinical Oncology · 1983 · 44 citations
1–5 of 13